Brief: 9 Meters Biopharma Announces Acquisition Of Humanized Anti-GIP Monoclonal Antibody From Lobesity
19/07/2021 13:49
July 19 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* 9 METERS BIOPHARMA INC - ANNOUNCES THE ACQUISITION OF
HUMANIZED
ANTI-GIP MONOCLONAL ANTIBODY FROM LOBESITY
* 9 METERS BIOPHARMA INC - IND-ENABLING STUDIES ONGOING WITH
FIRST-IN-HUMAN STUDIES ANTICIPATED IN 2023
Further company coverage: NMTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection